Berbice Capital Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$531K Sell
1,100
-700
-39% -$186K 0.28% 37
2026
Q1
$197K Hold
1,800
0.13% 52
2025
Q4
$299K Buy
1,800
+150
+9% +$25.1K 0.18% 46
2025
Q3
$323K Buy
1,650
+50
+3% +$8.22K 0.2% 46
2025
Q2
$145K Buy
1,600
+200
+14% +$15.8K 0.1% 61
2025
Q1
$83.5K Buy
1,400
+750
+115% +$69.4K 0.07% 68
2024
Q4
$86.1K Buy
+650
New +$61K 0.07% 67

Other funds holding ALAB

Berbice Capital Management's ALAB Position: Q2 2026 in Review

Berbice Capital Management reduced its Astera Labs (ALAB) stake by 39% in Q2 2026, selling an estimated $186K and leaving 1,100 shares worth $531K. The position accounts for 0.28% of the portfolio, ranked #37.

Berbice Capital Management first reported a position in ALAB in Q4 2024 and has held it in 7 quarters since. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Berbice Capital Management held 1,100 shares of Astera Labs worth $531K as of Q2 2026.
  • Berbice Capital Management sold 700 Astera Labs shares in Q2 2026, an estimated $186K.
  • Astera Labs made up 0.28% of Berbice Capital Management's portfolio in Q2 2026, its #37 holding.
  • Berbice Capital Management first reported a position in Astera Labs in Q4 2024 and has held it in 7 quarters since.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Berbice Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.